Back to search results

A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

Israel
Recruiting

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Recurrent Squamous Cell Carcinoma

Locations
  • Banner Health MD Anderson Phoenix, Gilbert, Arizona, United States
  • Dignity Health Cancer Institute, Phoenix, Arizona, United States
  • Alliance Dermatology, Phoenix, Arizona, United States
  • UCLA, Los Angeles, California, United States
  • Day Star Skin and Cancer Center, DeLand, Florida, United States
  • Integrity Research Clinical Associates, Delray Beach, Florida, United States
  • Palm beach Dermatology Group, Delray Beach, Florida, United States
  • Hollywood Dermatology, Hollywood, Florida, United States
  • University of Miami, Miami, Florida, United States
  • Baptist Health South Florida MCI, Miami, Florida, United States
  • Moffitt Cancer Center, Tampa, Florida, United States
  • Beer Dermatology, West Palm Beach, Florida, United States
  • Emory University, Atlanta, Georgia, United States
  • Mayo Clinic Rochester, Rochester, Minnesota, United States
  • Schweiger Dermatology Group, Hackensack, New Jersey, United States
  • New Mexico Cancer Center, Albuquerque, New Mexico, United States
  • Bassett Healthcare Network, Cooperstown, New York, United States
  • Northwell Health, Queens, New York, United States
  • New York Medical Skin Solutions, Rockaway Park, New York, United States
  • MDCS Dermatology, Smithtown, New York, United States
  • West Cancer Center, Germantown, Tennessee, United States
  • Gulf Coast Cancer Center, Houston, Texas, United States
  • University Cancer & Diagnostic Center, Houston, Texas, United States
  • University of Virginia Health System, Charlottesville, Virginia, United States
  • Dermatology of Seattle and Bellevue, Bellevue, Washington, United States
  • Princess Margaret Cancer Center, Toronto, Ontario, Canada
  • Rambam Medical Center, Haifa, Israel
  • Hadassah Medical Center, Jerusalem, Israel
  • Belinson-Rabin Medical Center, Petah Tikva, Israel
  • Sheba Medical Center, Ramat Gan, Israel
View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)